Safety, Tolerability, and Pharmacokinetic Evaluation of Single and Multiple Doses of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib in Healthy Japanese and White Adults

por Usansky, Helen, Yoon, Esther, Teper, Ariel, Zou, Jun, Fernandez, Carlos
Publicado 2022

Relieving nasal congestion in children with seasonal and perennial allergic rhinitis: efficacy and safety studies of mometasone furoate nasal spray

por Meltzer, Eli O, Baena-Cagnani, Carlos E, Gates, Davis, Teper, Ariel
Publicado 2013

Safety, Tolerability, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder for Pulmonary Hypertension: A Phase 1, Randomized, Double-Blind, Single- and Multiple-Dose Stu...

por Ismat, Fraz A., Usansky, Helen H., Villa, Raul, Zou, Jun, Teper, Ariel
Publicado 2022

Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis

por Chalmers, James D., Usansky, Helen, Rubino, Christopher M., Teper, Ariel, Fernandez, Carlos, Zou, Jun, Mange, Kevin C.
Publicado 2022

Benefit−risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis

por Chalmers, James D., Metersky, Mark L., Feliciano, Joseph, Fernandez, Carlos, Teper, Ariel, Maes, Andrea, Hassan, Mariam, Chatterjee, Anjan
Publicado 2023

Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial

por Cipolla, David, Zhang, Jimin, Korkmaz, Brice, Chalmers, James D., Basso, Jessica, Lasala, Daniel, Fernandez, Carlos, Teper, Ariel, Mange, Kevin C., Perkins, Walter R., Sullivan, Eugene J.
Publicado 2023

Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma

por Corren, Jonathan, Katelaris, Constance H., Castro, Mario, Maspero, Jorge F., Ford, Linda B., Halpin, David M.G., Rice, Megan S., Radwan, Amr, Deniz, Yamo, Rowe, Paul J., Teper, Ariel, Djandji, Michel
Publicado 2021

Dupilumab efficacy in adolescents with uncontrolled, moderate‐to‐severe asthma: LIBERTY ASTHMA QUEST

por Maspero, Jorge F., FitzGerald, John Mark, Pavord, Ian D., Rice, Megan S., Maroni, Jaman, Rowe, Paul J., Pirozzi, Gianluca, Amin, Nikhil, Ruddy, Marcella, Graham, Neil M. H., Teper, Ariel, Hardin, Megan
Publicado 2021

Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma

por Castro, Mario, Rabe, Klaus F., Corren, Jonathan, Pavord, Ian D., Katelaris, Constance H., Tohda, Yuji, Zhang, Bingzhi, Rice, Megan S., Maroni, Jaman, Rowe, Paul, Pirozzi, Gianluca, Amin, Nikhil, Ruddy, Marcella, Akinlade, Bolanle, Graham, Neil M.H., Teper, Ariel
Publicado 2020

Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function

por Pavord, Ian D, Siddiqui, Salman, Papi, Alberto, Corren, Jonathan, Sher, Lawrence D, Bardin, Philip, Langton, David, Park, Hae-Sim, Rice, Megan S, Deniz, Yamo, Rowe, Paul, Staudinger, Heribert W, Patel, Naimish, Ruddy, Marcella, Graham, Neil M H, Teper, Ariel
Publicado 2020

Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Se...

por Busse, William W., Maspero, Jorge F., Rabe, Klaus F., Papi, Alberto, Wenzel, Sally E., Ford, Linda B., Pavord, Ian D., Zhang, Bingzhi, Staudinger, Heribert, Pirozzi, Gianluca, Amin, Nikhil, Akinlade, Bolanle, Eckert, Laurent, Chao, Jingdong, Graham, Neil M. H., Teper, Ariel
Publicado 2018